148 related articles for article (PubMed ID: 15977265)
1. Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).
Yee KM; Buller CE; Catellier D; Cohen EA; Carere RC; Anderson T; Berger P; Burton JR; Barbeau G; Teo KK; Dzavik V;
Catheter Cardiovasc Interv; 2005 Oct; 66(2):178-84. PubMed ID: 15977265
[TBL] [Abstract][Full Text] [Related]
2. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA).
Buller CE; Dzavik V; Carere RG; Mancini GB; Barbeau G; Lazzam C; Anderson TJ; Knudtson ML; Marquis JF; Suzuki T; Cohen EA; Fox RS; Teo KK
Circulation; 1999 Jul; 100(3):236-42. PubMed ID: 10411846
[TBL] [Abstract][Full Text] [Related]
3. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis.
Woudstra P; Damman P; Beijk MA; Grundeken MJ; Harskamp RE; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Tijssen JG; de Winter RJ
Catheter Cardiovasc Interv; 2013 Jan; 81(1):26-33. PubMed ID: 22511590
[TBL] [Abstract][Full Text] [Related]
5. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG
Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768
[TBL] [Abstract][Full Text] [Related]
6. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.
Dzavik V; Carere RG; Teo KK; Knudtson ML; Marquis JF; Buller CE
Can J Cardiol; 1998 Jun; 14(6):825-32. PubMed ID: 9676168
[TBL] [Abstract][Full Text] [Related]
7. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
[TBL] [Abstract][Full Text] [Related]
8. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
9. Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).
Dzavik V; Carere RG; Mancini GB; Cohen EA; Catellier D; Anderson TE; Barbeau G; Lazzam C; Title LM; Berger PB; Labinaz M; Teo KK; Buller CE;
Am Heart J; 2001 Aug; 142(2):301-8. PubMed ID: 11479470
[TBL] [Abstract][Full Text] [Related]
10. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.
Van Belle E; Bauters C; Hubert E; Bodart JC; Abolmaali K; Meurice T; McFadden EP; Lablanche JM; Bertrand ME
Circulation; 1997 Sep; 96(5):1454-60. PubMed ID: 9315531
[TBL] [Abstract][Full Text] [Related]
11. Indications of coronary angioplasty and stenting in 2003: what is left to surgery?
Poyen V; Silvestri M; Labrunie P; Valeix B
J Cardiovasc Surg (Torino); 2003 Jun; 44(3):307-12. PubMed ID: 12832982
[TBL] [Abstract][Full Text] [Related]
12. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
[TBL] [Abstract][Full Text] [Related]
13. Stenting versus non-stenting after revascularization of chronic total coronary artery occlusion: short- and long-term clinical and angiographic results.
Dong S; Jeong M; Cho J; Kang J
Chin Med J (Engl); 2000 Mar; 113(3):222-4. PubMed ID: 11775250
[TBL] [Abstract][Full Text] [Related]
14. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
15. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results.
Rodríguez A; Ayala F; Bernardi V; Santaera O; Marchand E; Pardiñas C; Mauvecin C; Vogel D; Harrell LC; Palacios IF
J Am Coll Cardiol; 1998 Nov; 32(5):1351-7. PubMed ID: 9809947
[TBL] [Abstract][Full Text] [Related]
16. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.
West NE; Ruygrok PN; Disco CM; Webster MW; Lindeboom WK; O'Neill WW; Mercado NF; Serruys PW
Circulation; 2004 Feb; 109(7):867-73. PubMed ID: 14757691
[TBL] [Abstract][Full Text] [Related]
17. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
[TBL] [Abstract][Full Text] [Related]
18. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
[TBL] [Abstract][Full Text] [Related]
19. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
Lasala JM; Cox DA; Morris DL; Breall JA; Mahoney PD; Horwitz PA; Shaw D; Hood KL; Mandinov L; Dawkins KD
Am J Cardiol; 2009 Jun; 103(12):1663-71. PubMed ID: 19539073
[TBL] [Abstract][Full Text] [Related]
20. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
